The risk of Alzheimer disease (AD) increases with age, family history and informative genetic variants. Sadly, there is still no cure or means of prevention. As in other complex diseases …
KE Tansey, D Cameron, MJ Hill - Genome medicine, 2018 - Springer
Background Genome-wide association studies of Alzheimer's disease (AD) have identified a number of significant risk loci, the majority of which lie in non-coding regions of the genome …
Abstract Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated …
DP Wightman, IE Jansen, JE Savage, AA Shadrin… - MedRxiv, 2020 - medrxiv.org
Late-onset Alzheimer's disease is a prevalent age-related polygenic disease that accounts for 50-70% of dementia cases. Late-onset Alzheimer's disease is caused by a combination …
Epigenome-wide association studies of Alzheimer's disease have highlighted neuropathology-associated DNA methylation differences, although existing studies have …
S Khanna, D Domingo-Fernández, A Iyappan… - Scientific reports, 2018 - nature.com
Alzheimer's Disease (AD) is among the most frequent neuro-degenerative diseases. Early diagnosis is essential for successful disease management and chance to attenuate …
Introduction Exploring the role of Alzheimer's disease (AD) implicated pathways in the predementia phase may provide new insight for preventive and clinical trials targeting …
Genome-wide association studies have identified dozens of loci that alter the risk to develop Alzheimer's disease. However, with the exception of the APOE-ε4 allele, most variants bear …
SF Foley, KE Tansey, X Caseras, T Lancaster… - Biological …, 2017 - Elsevier
Background Recent genome-wide association studies have identified genetic loci that jointly make a considerable contribution to risk of developing Alzheimer's disease (AD). Because …